Biomarkers to monitor the prognosis, disease severity, and treatment efficacy in coronary artery disease

Expert Rev Cardiovasc Ther. 2023 Sep 29. doi: 10.1080/14779072.2023.2264779. Online ahead of print.ABSTRACTINTRODUCTION: Coronary Artery Disease (CAD) is a prevalent condition characterized by the presence of atherosclerotic plaques in the small coronary arteries of the heart. The global burden of CAD has increased significantly over the years, resulting in millions of deaths annually and making it the leading healthcare expenditure and cause of mortality in developed countries. The lack of cost-effective strategies for monitoring the prognosis of CAD warrants a pressing need for accurate and efficient markers to assess disease severity and progression, both for reducing healthcare costs and improving patient outcomes.AREA COVERED: To effectively monitor CAD, prognostic biomarkers and imaging techniques play a vital role in risk-stratified patients during acute treatment and over time. However, with over 1,000 potential markers of interest, it is crucial to identify the key markers with substantial utility in monitoring CAD progression and evaluating therapeutic interventions. This review focuses on identifying and highlighting the most relevant markers for monitoring CAD prognosis and disease severity. We searched for relevant literature using PubMed and Google Scholar.EXPERT OPINION: By utilizing the markers discussed, healthcare providers can improve patient care, optimize treatment plans, and ultimately reduce healthcare costs associated with CAD management.PMID:37772751 ...
Source: Expert Review of Cardiovascular Therapy - Category: Cardiology Authors: Source Type: research